1.Application status of odds ratio for medical animal experiments
Qiong CHI ; Zehong ZOU ; Yiling FU ; Ailin TAO
Chinese Pharmacological Bulletin 2010;26(3):408-410
Aim To study the application status of odds ratio for medical animal experiments.Methods Odds ratio and seven kinds of animal models were used as retrieval strategy to search medical animal experiment related papers in several Chinese and English databases.Papers relating to each kind of animal model and using odds ratio in abstract and text were counted. Data from different databases were compared. Calculation of odds ratio was exemplified and the significance of different odds ratio values was illustrated in this paper.Results Few medical animal experiments cited odds ratio as statistics.Conclusions The importance of odds ratio has not been fully recognized in Chinese references.
2.Efficacy of budesonide/formoterol powder for inhalation in treatment of patients with bronchial asthma
Haizhen JIN ; Jiyang ZHENG ; Xinjian DAI ; Qiong CHI ; Wantie WANG
Chinese Journal of Biochemical Pharmaceutics 2015;(12):100-101
Objective To observe the clinical effect of therapy of budesonide/formoterol powder for inhalation in treatment of adult with bronchial asthma.Methods 90 cases with bronchial asthma and were divided into observation group and control group randomly from February 2014 to February 2015.45 cases in each group.Control group was treated with budesonide inhalants +formoterol inhalants, observation group was given budesonide/formoterol powder inhalation.Changes of related indicators were followed up and recorded.Results After treatment, IL-5, IL-12 and IFN-γwere (60.2 ±9.7)pg/mL,(31.4 ±3.1)pg/mL,(1.6 ±0.2) ng/mL of observation group were better than control group (72.8 ±10.7)pg/mL,(38.5 ± 5.6)pg/mL,(2.3 ±0.3) ng/mL (P<0.05).After treatment,total effective rate in observation group was 68.9%, which was better than control group (48.9%)(P<0.05).Conclusion Clinical effect of budesonide/formoterol powder for inhalation in treatment of patients with bronchial asthma is accurate, and there is no obvious adverse reaction.
3.Autophagy inhibition enhances radiosensitivity of esophageal squamous carcinoma Eca-109 cells
Chi LU ; Zhang LEI ; Qiong FENG ; Ting LU ; Hongda LU
Chinese Journal of Radiological Medicine and Protection 2015;35(3):165-170
Objective To investigate the role of autophagy in radiation-induced death process of human esophageal squamous carcinoma Eca-109 cells.Methods Esophageal carcinoma cell line Eca-109 was divided into 6 groups of control,5 mmol/L 3-Methyladenine treatment,10 mmol/L treatment,6 Gy irradiation,irradiation + 5 mmol/L drug,and irradiation + 10 mmol/L drug.Some cells were transferred with GFP-LC3 plasmid and the changes of autophagosome were obserred.After each treatment,the expression of autophagy marker LC3B was measured by Western Blot,cell viability was detected by MTT,morphological characteristics of apoptosis cells were stained with a fluorescein of Hoechst 33342 and the percentage of apoptotic cells and cell cycle distribution were measured by flow cytometry.Clonogenic survival were used to evaluate the cell radiosensitivity.Results Autophagy level was increased after radiation,and the LC3B Ⅱ expression and LC3B Ⅱ/LC3B Ⅰ ratio were significantly decreased by autophagy inhibitor 3-Methyladenine (F =25.64,P < 0.05).The number of autophagosome fluorescent foci were significantly increased in the GFP-LC3 transfected cells after radiation,but reduced by 3-Methyladenine (F =127.36,P < 0.05).Compared with radiation alone group,autophagy inhibition combined with radiation significantly decreased cell viability (F =129.54,P < 0.05) and colony formation,increased apoptosis and the percentage of G2/M-phase cells.Conclusions 3-Methyladenine enhances the radiosensitivity of esophageal squamous carcinoma Eca-109 cells,suggesting that inhibition of autophagy could be used as an adjuvant treatment of radiotherapy in esophageal squamous carcinoma.
4.Clinical research on conservative treatment and surgical treatment for bronchiectasis
Risheng HUANG ; Zhiyi LIN ; Liangda JIN ; Lixiang ZHANG ; Xiaofeng CHEN ; Shenxian CHEN ; Qiong CHI
Chinese Journal of Primary Medicine and Pharmacy 2010;17(22):3025-3027
Objective To compare the curative effect of conservative treatment and surgical treatment for bronchiectasis. Methods 60 patients with bronchiectasis were randomly divided into observation group and control group,30 cases in each group,they were treated with surgery and medical therapy respectively,the clinical efficacy,length of stay, costs, remission time of symptoms and signs, changes of blood gas index and ESR, CRP,TNF-α, WBC,NEUT of the two groups after treatment were compared. Results The curative rate of observation group was significandy higher than control group, while the length of stay, remission time of symptoms and signs and hospitalization costs were significantly lower than control group, the difference was statistically significant (all P <0.05) ;After treatmenit,the blood gas index of both groups improved significantly than before treatment(all P < 0.05), and the blood gas index of observation group improved significantly than the control group (all P < 0. 05); After treatment, ESR, CRP,TNF-α,WBC and NEUT of both groups were significantly decreased compared with those before treatment(all P <0. 05); Between the two groups, the index value of the observation group decreased significantly (all P < 0.05).Conclusion Surgical treatment for bronchiectasis was superior to conservative treatment with better curative effect,lower cost, shorter hospital stay and faster relief of symptoms and signs, it had good prospects to be applied.
5.Sarcoidosis of kidney: report of a case.
Qiong-zhen LIN ; Li-hong ZHANG ; Hai-ying LIN ; Yan-qing CHI ; Bao-xing WANG ; Ying LI ; Wan-zhong ZOU
Chinese Journal of Pathology 2007;36(1):62-63
Adult
;
Biopsy, Needle
;
Diagnosis, Differential
;
Humans
;
Kidney
;
pathology
;
Kidney Diseases
;
pathology
;
therapy
;
Male
;
Nephritis, Interstitial
;
pathology
;
Renal Dialysis
;
Sarcoidosis
;
pathology
;
therapy
;
Tuberculosis, Renal
;
pathology
6.Clinicopathological characteristics and immuophenotype analysis of pul-monary sclerosing hemangioma
China Modern Doctor 2015;53(35):106-109
Objective To observe the clinicopathological characteristics of pulmonary sclerosing hemangioma(PSH) and to analyze its expression and significance in immunohistochemistry,in order to improve the understanding and diagnostic level of this diesease. Methods The clinicopathological features of 6 patients with PSH in Whenzhou Center Hospital from January 2011 to May 2015 were analyzed.Using immunohistochemical methods,the expression of NapsinA,P63, TTF-1,EMA,CK,Vimentin,SP-B,CgA,Syn,CD34 and MC were observed. Results PSH exhibited the following histo-logical features:papillary,solid,hemorrhagic,sclerotic,and mixed.The majority of tumors showed a mixed pattern of histology. The tumor was composed of two distinct cellular components,the cuboidal or surface cells and the round or polygonal or stroma cells.Immunohistochemical staining revealed the both kinds of cells expressed TTF-1 and EMA,the cuboidal cells expressed NapsinA, P63, CK and SP-B,the round or polygonal cells expressed Vimentin.Neither of these two types of cells expressed MC,CD34 and Syn.Sporadic expression of CgA was observed in one case. Conclusion PSH is a rare lung tumor,with various histologie appearance,and often misdiagnosed as lung cancer. The immunohistochemical detection not only suggested that the tumor originates from the multiple potential of the primary respiratory epithelium, but also had important value in the diagnosis and differential diagnosis of PSH.
7.Application of ThinPrep cytology test in the diagnosis of lung cancer.
Qiong CHI ; Ji-yang ZHENG ; Xin-jian DAI ; Yong-ke ZHENG ; Shen-xian CHEN ; Hai-miao XU ; Xiao-ping HUANG
Chinese Journal of Oncology 2010;32(3):221-224
OBJECTIVETo explore the diagnostic value of ThinPrep cytology test (TCT) in lung cancer.
METHODS353 cases of bronchoalveolar lavage fluid (BALF) and(or) bronchial brushing cytology (192 cases from lung cancer patients and 161 cases from benign lung disease patients) were detected with TCT and method of direct smear, respectively. The sensitivity and specificity of two methods was compared.
RESULTSThe sensitivity and specificity of TCT were 39.6% and 99.4%. And which of direct smear method were 8.3% and 100%, respectively. The sensitivity of TCT was significantly higher than that of method of direct smear in the diagnosis of lung cancer (P < 0.01). There were 71 patients who underwent BALF and bronchial brushing cytology simultaneously, the sensitivity of TCT of BALF was higher than that of bronchial brushing cytology (P < 0.05). Of the 69 cases which had both TCT and histopathological results, TCT and pathology concordance rate was 84.1%.
CONCLUSIONTCT has more diagnostic value in lung cancer; BALF is more preponderant than bronchial brushing cytology by TCT in the diagnosis of lung cancer.
Adenocarcinoma ; diagnosis ; pathology ; Adult ; Aged ; Aged, 80 and over ; Biopsy ; Bronchi ; pathology ; Bronchoalveolar Lavage Fluid ; cytology ; Bronchoscopy ; Carcinoma, Small Cell ; diagnosis ; pathology ; Carcinoma, Squamous Cell ; diagnosis ; pathology ; Cytodiagnosis ; methods ; Cytological Techniques ; methods ; Female ; Humans ; Lung Neoplasms ; diagnosis ; pathology ; Male ; Middle Aged ; Pneumonia ; diagnosis ; pathology ; Sensitivity and Specificity ; Tuberculosis, Pulmonary ; diagnosis ; pathology ; Young Adult
8.Effect of obstructive sleep apnea syndrome on blood lipid and blood glucose in elderly hypertensive patients.
Sheng-qing ZHUO ; Xue-ping YANG ; Yong-chi CHEN ; Xiang-ting TIAN ; Huan LIAN ; Qiong OU
Journal of Southern Medical University 2009;29(2):330-332
OBJECTIVETo investigate the effect of obstructive sleep apnea syndrome (OSAS) on blood lipid and blood glucose in elderly hypertensive patients.
METHODa One hundred and seven elderly hypertensive patients received examinations by polysomnography and according to the apnea-hypopnea index (AHI), the patients were divided into four groups, namely uncomplicated hypertension group (n=23) and 3 hypertension groups with mild (n=31), moderate (n=29) and severe (n=24) OSAS. The fasting and 2-hour postprandial plasma glucose, glycosylated hemoglobin (HbA1c), total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), Apo-A, and Apo-B of these patients were measured.
RESULTSaCompared with the non-OSAS patients, all the OSAS patients showed increased fasting and 2-hour postprandial plasma glucose, HbA1c, TC, TG, LDL and TC/HDL, and the increments were statistically significant in severe OSAS patients (P<0.05). The level of HDL was lowered in the OSAS groups, showing significant difference between severe OSAS group and the non-OSAS group (P<0.05). Apo-A level was lowered and Apo-B increased in the OSAS groups, but the differences were not statistically significant (P>0.05).
CONCLUSIONSOSAS may produce harmful affect on the blood glucose and blood lipids in elderly hypertensive patients.
Aged ; Aged, 80 and over ; Blood Glucose ; metabolism ; Female ; Humans ; Hypertension ; blood ; complications ; Lipids ; blood ; Male ; Middle Aged ; Polysomnography ; Sleep Apnea, Obstructive ; blood ; complications
9.Effect of platelet factor 4 on the adherence of cord blood CD34(+) cells.
Shi-hong LU ; Yi FENG ; Ren-chi YANG ; Yong-jun LIU ; Qiong-li ZHAI ; Zhi-hua ZHANG ; Zhong-chao HAN
Chinese Journal of Hematology 2003;24(9):467-469
OBJECTIVETo investigate the effects of platelet factor 4 (PF4) on the adherence, and the expressions of adherent molecules CD(49d) and CXCR4 and the receptor of SDF-1 of fresh and expanded cord blood CD(34)(+) cells.
METHODSCD(34)(+) cells were isolated from cord blood using MACS immune magnetic beads. The adherent ability was assayed by using crystal violet staining and the expression of adherent molecule CD(49d) and CXCR4 by FACS.
RESULTS(1) PF4 could increase the adherent ability of the fresh cord blood CD(34)(+) cells, the effect being positively correlated with the dose of PF4. (2) SDF-1 at concentration of 100 ng/ml increased the adherent ability of the fresh cord blood CD(34)(+) cells. (3) The spontaneous and the SDF-1 induced adherent ability of the cord blood CD(34)(+) cells began to decrease after being cultured for 10 days without PF4, while in the presence of PF4 at 100 ng/ml, the ability of the cord blood CD(34)(+) cell adhering to the stroma layer still remained at higher level. At day 14, the adherent ability was (262.04 +/- 64.81)% and (64.35 +/- 8.29)% in PF4 group and control group, respectively, if it was defined as 100% at day 0. SDF-1 at concentration of 100 ng/ml induced adherent ability was (138.31 +/- 32.39)% and (67.66 +/- 12.44)% in PF4 group and control group, respectively. (4) The expression of CD(49d) and CXCR4 increased 13.02% and 17.33%, respectively, when incubated with PF4.
CONCLUSIONSPF4 could increase the adherent ability and promote the expression of CD(49d) and CXCR4 of the cord blood CD(34)(+) cells, suggesting that PF4 promote the circulating stem cells homing to the marrow in the process of stem cells transplantation.
Antigens, CD34 ; blood ; Cell Adhesion ; drug effects ; Fetal Blood ; cytology ; Flow Cytometry ; Hematopoietic Stem Cells ; cytology ; drug effects ; Humans ; Integrin alpha4 ; blood ; Platelet Factor 4 ; pharmacology ; Receptors, CXCR4 ; blood
10.A phase II trial of oxaliplatin plus S-1 as a first-line chemotherapy for patients with advanced gastric cancer.
Lin YANG ; Yan SONG ; Ai-Ping ZHOU ; Qiong QIN ; Yihebali CHI ; Jing HUANG ; Jin-Wan WANG
Chinese Medical Journal 2013;126(18):3470-3474
BACKGROUNDPalliative chemotherapy has been shown to have a survival benefit for patients with recurrent or metastatic gastric cancer. We conducted a Phase II trial to determine the efficacy and safety of S-1 plus oxaliplatin (SOX regimen) as first-line chemotherapy for patients with unresectable locally advanced or metastatic gastric cancer.
METHODSEligible patients had measurable lesions and no previous history of chemotherapy (except adjuvant chemotherapy). Oxaliplatin was administered intravenously at a dose of 130 mg/m(2) on day 1. S-1 was administered orally in doses of 80, 100, or 120 mg/d according to body surface areas of <1.25 m(2), 1.25-1.5 m(2), or >1.5 m(2) respectively; the total dose was divided into two daily doses on days 1-14. Treatments were repeated every 3 weeks until disease progression or intolerable toxicity occurred.
RESULTSForty-three patients were enrolled in the study. All were assessable for efficacy and adverse events. The objective response and disease control rates were 55.8% and 76.7% respectively. The median follow-up time was 16.5 months. The median progression-free survival time was 7 months (95% CI, 5.8-8.2 months) and the median overall survival time was 16.5 months (95% CI, 9.7-23.3 months). The one-year survival rate was 54.2%. Major adverse reactions were grade 3/4 neutropenia (9.3%) and thrombocytopenia (20.9%).
CONCLUSIONThe SOX regimen with oxaliplatin at a dose of 130 mg/m(2) was found to be effective and safe as a first-line chemotherapy in Chinese patients with advanced gastric cancer.
Adult ; Aged ; Antineoplastic Agents ; therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Organoplatinum Compounds ; therapeutic use ; Stomach Neoplasms ; drug therapy ; Treatment Outcome